123 related articles for article (PubMed ID: 11843170)
1. Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus.
Sari RA; Taysi S; Erdem F; Yilmaz O; Keleş S; Kiziltunç A; Odabaş AR; Cetinkaya R
Rheumatol Int; 2002 Jan; 21(4):149-52. PubMed ID: 11843170
[TBL] [Abstract][Full Text] [Related]
2. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus.
Tulek N; Aydintug O; Ozoran K; Tutkak H; Duzgun N; Duman M; Tokgoz G
Clin Rheumatol; 1996 Jan; 15(1):47-50. PubMed ID: 8929775
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus.
Sfikakis PP; Charalambopoulos D; Vayiopoulos G; Oglesby R; Sfikakis P; Tsokos GC
Clin Exp Rheumatol; 1994; 12(1):5-9. PubMed ID: 7909280
[TBL] [Abstract][Full Text] [Related]
4. Soluble intercellular adhesion molecule-1 in paediatric connective tissue diseases.
Laucella SA; Gaddi E; Balbaryski J; Giraudi V; Cuttica RJ
Acta Paediatr; 1999 Apr; 88(4):399-403. PubMed ID: 10342537
[TBL] [Abstract][Full Text] [Related]
5. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
6. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
Wais T; Fierz W; Stoll T; Villiger PM
J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
[TBL] [Abstract][Full Text] [Related]
8. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus.
Machold KP; Kiener HP; Graninger W; Graninger WB
Clin Immunol Immunopathol; 1993 Jul; 68(1):74-8. PubMed ID: 8099860
[TBL] [Abstract][Full Text] [Related]
9. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
10. Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus.
Egerer K; Feist E; Rohr U; Pruss A; Burmester GR; Dörner T
Lupus; 2000; 9(8):614-21. PubMed ID: 11035437
[TBL] [Abstract][Full Text] [Related]
11. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study.
Spronk PE; Bootsma H; Huitema MG; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1994 Sep; 97(3):439-44. PubMed ID: 7521807
[TBL] [Abstract][Full Text] [Related]
12. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
Kaplanski G; Cacoub P; Farnarier C; Marin V; Grégoire R; Gatel A; Durand JM; Harlé JR; Bongrand P; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):55-64. PubMed ID: 10643700
[TBL] [Abstract][Full Text] [Related]
13. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity.
Boehme MW; Raeth U; Galle PR; Stremmel W; Scherbaum WA
Clin Exp Immunol; 2000 Jan; 119(1):189-95. PubMed ID: 10606982
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
Srivastava MD; Rossi TM; Lebenthal E
Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
[TBL] [Abstract][Full Text] [Related]
15. Circulating intercellular adhesion molecule 1 as a new activity marker in patients with systemic lupus erythematosus.
Kling E; Bieg S; Boehme M; Scherbaum WA
Clin Investig; 1993 Apr; 71(4):299-304. PubMed ID: 8097124
[TBL] [Abstract][Full Text] [Related]
16. Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance.
Tso TK; Huang WN
J Rheumatol; 2007 Apr; 34(4):726-30. PubMed ID: 17309130
[TBL] [Abstract][Full Text] [Related]
17. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis.
Janssen BA; Luqmani RA; Gordon C; Hemingway IH; Bacon PA; Gearing AJ; Emery P
Br J Rheumatol; 1994 Dec; 33(12):1112-6. PubMed ID: 7528085
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin levels in women with systemic lupus erythematosus.
Garcia-Gonzalez A; Gonzalez-Lopez L; Valera-Gonzalez IC; Cardona-Muñoz EG; Salazar-Paramo M; González-Ortiz M; Martínez-Abundis E; Gamez-Nava JI
Rheumatol Int; 2002 Aug; 22(4):138-41. PubMed ID: 12172951
[TBL] [Abstract][Full Text] [Related]
19. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.
Kobayashi H; Hosono O; Mimori T; Kawasaki H; Dang NH; Tanaka H; Morimoto C
J Rheumatol; 2002 Sep; 29(9):1858-66. PubMed ID: 12233879
[TBL] [Abstract][Full Text] [Related]
20. Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage.
Molad Y; Miroshnik E; Sulkes J; Pitlik S; Weinberger A; Monselise Y
Clin Exp Rheumatol; 2002; 20(3):403-6. PubMed ID: 12102480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
